Abstract
[This corrects the article DOI: 10.3389/fneur.2018.00759.].
Highlights
Specialty section: This article was submitted to Neuropharmacology, a section of the journal Frontiers in Neurology
The total number of one reference was wrongly included in the calculation of the endpoint efficacy over 70%
Data from one reference was missing in the calculation of the endpoints mild AE and severe AE
Summary
Specialty section: This article was submitted to Neuropharmacology, a section of the journal Frontiers in Neurology. 1 Entourage Phytolab, São Paulo, Brazil, 2 Bedrocan Brasil, São Paulo, Brazil, 3 UNICAMP, Campinas, Brazil A Corrigendum on Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis by Pamplona, F.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
